Effects of substitution with thyroxine on the thyrotrophin (TSH) response to thyrotrophin-releasing hormone (TRH) in severe primary myxoedema and in mild hypothyroidism following prolonged thyrostatic therapy.
D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000009:adverse effects; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D009230:Myxedema / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D010903:Pituitary Gland, Anterior / Q000378:metabolism / Q000503:physiopathology*; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000627:therapeutic use*; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D013956:Antithyroid Agents; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013974:Thyroxine